🔎 Trials Near Me

Hjem › Ewing-sarkom › Pennsylvania

Ewing-sarkom kliniske forsøg i Pennsylvania

10 studier for Ewing-sarkom søger deltagere på steder i Pennsylvania.

Byer i Pennsylvania

Officiel studietekst (engelsk)

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

  • Childrens Hospital of Philadelphia, Philadelphia
RekruttererFase 1
Alder 2 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07297979

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
RekruttererFase 1/2
6 Months – 25 Years · Alle køn · Opdateret 17. sep. 2026 · NCT06395103

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Children's Hospital of Philadelphia- Center for Childhood Cancer Research, Philadelphia
  • University of Pennsylvania Abramson Cancer Center, Philadelphia
RekruttererFase 1
Alder 12 til 85 · Alle køn · Opdateret 8. sep. 2026 · NCT03715933

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

  • Children's Hospital of Philadelphia, Philadelphia
  • University of Pennsylvania, Philadelphia
RekruttererFase 1
Alder 5 til 40 · Alle køn · Opdateret 3. sep. 2026 · NCT06156410

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
RekruttererFase 1/2
Op til 26 år · Alle køn · Opdateret 3. sep. 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
RekruttererFase 1/2
Op til 30 år · Alle køn · Opdateret 3. sep. 2026 · NCT06541262

Lurbinectedin in FET-Fused Tumors

  • Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 1/2
Alder 10 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT05918640

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital of Philadelphia, Philadelphia
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

  • Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
RekruttererFase 2
Alder 0 til 50 · Alle køn · Opdateret 9. jul. 2026 · NCT07321912

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 1/2
Alder 2 til 30 · Alle køn · Opdateret 3. feb. 2026 · NCT05734066

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.